-
Product Insights
Cognoa Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Cognoa Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Cognoa Inc (Cognoa) develops digital diagnostic and therapeutic treatments for children with behavioural health conditions. The company offers Canvas Dx, an artificial intelligence based digital diagnosis aid to identify autism spectrum disorder in children. It is investigating a digital therapeutic to treat children with autism. The company is also evaluating solutions to identify and treat anxiety, speech and language, and...
-
Thematic Analysis
Digital Therapeutics and their Impact on Healthcare
Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescribed therapeutic interventions. There is a growing number of DTx developed on the market today as well as pipeline products in development following internationally-recognized, quality, design and manufacturing standards. DTx will provide a new approach to treatment and disease management in which patients have the possibility...